Genetic Disorder & Chromosomal Abnormalities

Genetic Disorders: Core Definition & Scope

  • A genetic disorder is any pathology arising from abnormalities in an individual’s DNA.

    • Abnormalities span a continuum:

    • Single–base substitutions ("point mutations").

    • Small or large deletions/insertions of genes.

    • Gain or loss of whole chromosomes or entire chromosome sets (genomic imbalance).

  • Epidemiology

    • Most single-gene or chromosomal conditions are rare, affecting 11 person in several 10310610^3-10^6 individuals.

Chromosome Fundamentals

  • Humans are diploid: 4646 chromosomes → 2222 homologous autosomal pairs + 11 pair of sex chromosomes (allosomes).

  • Conventional display = karyotype (e.g., male karyotype 46,XY46,XY).

Chromosomal Anomalies: Master Classification

  • Errors occur during meiosis (gametogenesis) or mitosis (somatic division).

  • Two umbrella categories

    1. Numerical anomalies (aneuploidy) – abnormal chromosome number.

    2. Structural anomalies – aberrant architecture of one or more chromosomes.

Numerical (Aneuploid) Anomalies

  • Monosomy – loss of one chromosome of a pair (e.g., Turner syndrome, 45,X45,X).

  • Trisomy – presence of three copies of a chromosome (e.g., Down syndrome, 47,+2147,+21).

  • Etiology: nondisjunction—failure of homologues or chromatids to segregate.

Structural Anomalies – Spectrum & Prototypical Disorders

  • Deletion – loss of a segment.

    • Wolf-Hirschhorn (4p–) & Cri-du-chat (5p–).

  • Duplication – repeat of a segment.

    • Charcot–Marie–Tooth type 1A: duplication of PMP22 on chromosome 1717.

  • Translocation – segment relocates to non-homologous chromosome.

    • Reciprocal – mutual exchange.

    • Robertsonian – entire acrocentric chromosome (13, 14, 15, 21, 22) fuses at centromere.

  • Inversion – segment breaks, rotates 180180^{\circ}, re-inserts.

  • Insertion – segment excised from one chromosome and inserted into another.

  • Clinical Pearl: Structural events may be de novo or inherited; parental karyotyping clarifies recurrence risk.

Inheritance Patterns of Genetic Disease

  1. Autosomal (non-sex chromosomes)

    • Dominant – one mutant allele suffices → affected offspring has 50 % risk per pregnancy if one parent affected.

    • Recessive – disease manifests only when both alleles are mutant → parents often carriers.

  2. Allosomal (sex-linked)

    • X-linked dominant†

    • X-linked recessive†

    • Y-linked (holandric) – transmitted father → son exclusively.

  3. Mitochondrial

    • Mutation in mtDNA or nuclear genes encoding mitochondrial proteins → ATP deficiency → organ failure.

    • Strict maternal inheritance (sperm carry virtually no mitochondria).

    • Prevalence ≈ 11 in 4,0004,000.

† Male hemizygosity for XX means recessive alleles manifest more readily in males.

Autosomal vs Allosomal Disorders – Key Contrasts

  • Mutation locus

    • Autosomal → chromosomes 1221–22.

    • Allosomal → sex chromosomes (mainly XX).

  • Sex predilection

    • Autosomal → affects both sexes equally.

    • Allosomal → males more often affected (hemizygosity).

  • Genotype of affected

    • Autosomal → can be homozygous or heterozygous, dominant or recessive.

    • Allosomal (recessive) → affected males are hemizygous.

  • Representative examples

    • Autosomal: Down syndrome, sickle-cell anemia.

    • Allosomal: Klinefelter syndrome, Turner syndrome.

Pre-disposing Cytogenetic Mechanisms for Autosomal Disease

  • Trisomy

  • Autosomal deletion

  • Microdeletion (sub-microscopic)

  • Chromosomal instability syndromes (e.g., Bloom, Fanconi anemia)

Trisomy (Polysomy) – Pathogenesis & Major Entities

  • Definition: Three copies of a chromosome (polysomic aneuploidy).

  • Origin: Nondisjunction during meiosis I, meiosis II, or (rarely) post-zygotic mitosis.

  • Survivable autosomal trisomies in humans

    1. Trisomy 21 – Down syndrome

    2. Trisomy 18 – Edwards syndrome

    3. Trisomy 13 – Patau syndrome

Trisomy 13 (Patau Syndrome)

  • Cytogenetics: 47,+1347,+13 or Robertsonian translocation involving chromosome 1313.

  • Incidence: 11 in 10,00021,70010{,}000–21{,}700 live births.

  • Multisystem phenotype

    • CNS: Severe intellectual disability, holoprosencephaly, absent corpus callosum, cerebellar hypoplasia.

    • Craniofacial: Microphthalmia, bilateral cleft lip/palate, sloping forehead, scalp defects.

    • Limbs: Post-axial polydactyly, rocker-bottom heels.

    • Visceral: Congenital heart and renal malformations.

  • Prognosis: High neonatal mortality; median survival < 11 year.

Trisomy 18 (Edwards Syndrome)

  • Cytogenetics: 47,+1847,+18.

  • Incidence: ≈ 11 in 6,0006{,}000 live births; ≈ 80 % are female.

  • Hallmark features

    • Growth: Intra-uterine growth restriction, low birth weight.

    • Craniofacial: Prominent occiput, micrognathia, low-set ears, short sternum, webbed neck.

    • Limbs: "Clenched fists" with overlapping fingers, hypoplastic nails, rocker-bottom feet.

    • Cardiac: Ventricular septal defects.

    • Renal anomalies.

  • Prognosis: Only <10 % survive beyond 11 year; profound cognitive impairment.

Trisomy 21 (Down Syndrome)

  • Cytogenetics: 9595 % due to free trisomy 21 via nondisjunction; 44 % Robertsonian translocation; 11 % mosaicism.

  • Discovery milestones

    • Clinical delineation by J. L. Down (1866).

    • Chromosomal basis identified by J. Lejeune (1959).

  • Epidemiology: Maternal age-dependent; overall ≈ 11 in 700700 live births.

  • Clinical spectrum

    • Intellectual disability: Mean IQ ≈ 5050 (vs. 100100 general population); cognitive decline with age.

    • Craniofacial: Brachycephaly, flat occiput & face, epicanthal folds, upward-slanting palpebral fissures, flat nasal bridge, Brushfield spots.

    • Oral: Protruding "scrotal" tongue, high-arched palate, dental anomalies.

    • Limbs: Single transverse palmar crease (simian crease), clinodactyly of 5th5^{th} finger, short broad hands.

    • Systemic: Hypotonia, congenital heart disease (AV canal, VSD), gastrointestinal atresia, increased leukemia & Alzheimer risk.

Autosomal Deletion Syndromes

  • Definition: Loss of chromosomal material on an autosome; may be microscopic (> 55 Mb) or sub-microscopic (microdeletion).

  • Common entities

    1. Wolf–Hirschhorn syndrome (4p–)

    2. Cri-du-chat syndrome (5p–)

    3. Langer–Giedion syndrome (8q23.1–q24.1)

Wolf–Hirschhorn Syndrome (WHS)

  • Genetics: Terminal deletion of short arm of chromosome 44 (critical region = 4p16.34p16.3).

  • Historical note: Described (1961) by Cooper & Hirschhorn; detailed by U. Wolf.

  • Key features

    • Craniofacial "Greek warrior helmet" appearance – high forehead, wide nasal bridge, short philtrum.

    • Microcephaly, seizures, severe growth & intellectual disability.

    • Hypotonia, immunodeficiency, renal anomalies, hearing loss.

Cri-du-chat Syndrome (Cat-Cry, 5p–)

  • Genetics: Deletion on short arm of chromosome 55 (critical region 5p15.25p15.2).

  • Incidence: ≈ 11 in 50,00050{,}000; female:male ≈ 44:33.

  • Diagnostic cry: High-pitched, cat-like due to laryngeal hypoplasia.

  • Clinical picture

    • Global developmental delay & intellectual disability.

    • GI & cardiac malformations.

    • Excessive drooling, behavioral disturbances.

Langer–Giedion Syndrome (Trichorhinophalangeal Syndrome II)

  • Genetics: Contiguous gene deletion at 8q24.11q24.138q24.11–q24.13.

  • Phenotype: Sparse hair, bulbous nose, multiple exostoses; included here for completeness (limited details in transcript).

Chromosomal Testing & Genetic Counseling

  • Parental karyotyping determines whether anomaly is de novo or inherited → influences recurrence risk.

  • Robertsonian carriers have  1015~10–15 % risk of Down syndrome in offspring if female, 131–3 % if male.

  • Ethical issues: Prenatal diagnosis, selective termination, psychosocial support.

Practical & Ethical Considerations

  • Early detection enables medical surveillance (e.g., cardiac echo in Down syndrome, renal ultrasound in Patau/Edwards).

  • Multidisciplinary care improves quality of life but raises resource-allocation questions.

  • Advances in CRISPR-based gene editing pose future therapeutic avenues yet raise germline-editing ethics.


These notes integrate foundational genetics, clinical correlates, epidemiology, and ethical reflections, providing a stand-alone study resource.